News - International | Osborne Clarke

NEWS

Latest news

Firm news, deals, comment and updates – from across our international locations

Featured news - International

Osborne Clarke in the news

International legal practice Osborne Clarke has again received strong recognition in one of the world’s leading independent legal directories, Chambers UK. This year, the firm has secured 65 practice area rankings and 121 individual rankings. Key achievements include new practice...

Life Sciences and Healthcare

International legal practice Osborne Clarke has advised Yazen Health, a Swedish digital healthcare provider specialising in medical obesity treatment, on its €50 million funding round led by European growth investor Verdane, with continued participation from existing investor Evli Growth Partners...

Osborne Clarke in the news

International legal practice Osborne Clarke has appointed Tom Webley as a partner in its Disputes & Risk team in London. Tom will play a key role in bolstering Osborne Clarke’s financial services litigation, as well as enhance the firm's bench...

Corporate

International legal practice Osborne Clarke has advised the selling shareholders of Blueleaf Care, a leading UK distributor of care and nursing home products, on its sale to Bunzl plc, the specialist international distribution and services group. The transaction highlights Osborne...

Corporate

International legal practice Osborne Clarke has advised the management team of SFG20, the UK industry standard for building maintenance specification, on Bowmark Capital’s investment in the business. Bowmark acquired a significant stake in SFG20 alongside the Building Engineering Services Association...

Corporate

International legal practice Osborne Clarke has advised Integrity Growth Partners, a Los Angeles-based growth private equity firm focused on software and technology-enabled services businesses, on its $22 million growth equity investment in Prevalent AI. The transaction demonstrates Osborne Clarke’s combined...

Osborne Clarke in the news

International legal practice Osborne Clarke has once again been recognised in the Legal 500 guide, performing strongly across its core sectors and the range of transactions, regulatory and disputes capabilities for which it is well-known. The firm has received particular...

Corporate

International legal practice Osborne Clarke has advised Alchera Technologies, an AI-powered data platform used by local authorities and highways operators across the UK, on its growth equity fundraising. The deal demonstrates Osborne Clarke’s expertise in supporting technology scale-ups, combining sector...

Corporate

International legal practice Osborne Clarke has advised long‑standing client GoHenry, a UK money app helping 6-18-year olds learn to earn, save, spend and invest, on regulatory matters connected with the sale of GoHenry’s UK business to Barclays Bank UK PLC...

Osborne Clarke in the news

Osborne Clarke has been named Legal Technology Team of the Year at the 2026 Legal Business Awards for its work with a leading UK housebuilder, Crest Nicholson, to design and implement a data‑driven, platform‑based model for managing its panel legal...

Corporate

Osborne Clarke is opening a new office in Frankfurt am Main on 1 September, significantly enhancing its European capability in private equity, M&A, finance, technology and corporate. The opening extends Osborne Clarke's presence in one of Europe's key financial centres...

Corporate

Osborne Clarke Netherlands has advised Casper Bakker and Stephan Groen, founders and CEOs of Picqer, on the sale of Logict B.V. and its subsidiary Picqer B.V. to Katapull (EntraCommerce B.V.), a Rotterdam-based commerce platform backed by NedVest. The transaction brings...

Osborne Clarke in the news

International legal practice Osborne Clarke announces a new office just opened in Luxembourg, placing it at the centre of European private equity and funds activity and significantly enhancing its European capability. It will advise on fund formation, private equity and...

Belgium

China

France

Germany

India

Italy

Luxembourg

The Netherlands

Poland

Singapore

Spain

Sweden

UK

USA

Latest news

Featured news - International

Osborne Clarke celebrates continued success in Chambers UK, as 2027 rankings are published

Osborne Clarke Sweden advises digital healthcare provider Yazen Health on €50 million funding round

Osborne Clarke appoints new partner Tom Webley to Disputes & Risk team

Osborne Clarke advises Blueleaf Care shareholders on sale to Bunzl

Osborne Clarke advises SFG20 management team on investment by Bowmark Capital

Osborne Clarke advises Integrity Growth Partners on $22 million investment in Prevalent AI

Osborne Clarke secures Tier 1 TMT ranking and climbs in Media: Video Games category in Legal 500 UK 2027

Osborne Clarke advises Alchera Technologies on growth equity fundraising

Osborne Clarke advises GoHenry ahead of Barclays acquisition

Osborne Clarke wins Legal Technology Team of the Year at the Legal Business Awards

Osborne Clarke expands European reach with new Frankfurt office, strengthening private capital and transaction offering

Osborne Clarke advises Picqer founders on sale to Katapull

Osborne Clarke opens Luxembourg office, strengthening European private markets and funds offering

All news

Osborne Clarke successfully advises AGESP Energia S.r.l. before the Court of Rome in relation to ARERA's regulation of the natural gas default service

UWE Bristol and local law firms launch talent collaboration programme for Black, Asian and Minority Ethnic students

Osborne Clarke advises Highland Europe on follow-on investment into insurance pricing software hyperexponential

Osborne Clarke assists Fiat Republic in acquiring their e-money licence in the Netherlands

Osborne Clarke advises crypto broker Anycoin Direct on BaFin licence application

Osborne Clarke announces the promotion of three Counsels

Osborne Clarke continues to invest in Sweden and the Nordics – appointing new Partner and Built Environment Head

Osborne Clarke advised PCM Trials on the acquisition of Clinical Trial Service

Sign up for our newsletter

Legal Notice